Effect of leaving against medical advice on 30-day infective endocarditis readmissions

Harshith S Thyagaturu1, Alexander Bolton2, Sittinun Thangjui3

  • 1Department of Cardiology, Heart and Vascular Institute, West Virginia University, Morgantown, West Virginia, USA.

Insights

Patients with infective endocarditis (IE) leaving against medical advice (AMA) face significantly higher 30-day readmission risks. Addressing this requires understanding the high prevalence of injection drug use and mental health needs in IE AMA patients.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • The impact of patients leaving against medical advice (AMA) on infective endocarditis (IE) readmission rates remains understudied.
  • Infective endocarditis is a serious condition with significant healthcare implications.

Purpose of the Study:

  • To investigate the association between leaving against medical advice (AMA) and 30-day readmission rates in infective endocarditis (IE) patients.
  • To compare the characteristics and readmission risks of IE patients discharged AMA versus those discharged conventionally.

Main Methods:

  • Utilized the National Readmissions Database (2016-2019) to identify IE patients.
  • Categorized patients into those discharged AMA (IE AMA) and those discharged to home or facility (IE non-AMA).
  • Analyzed 30-day all-cause readmissions as the primary outcome, adjusting for patient characteristics.

Main Results:

  • 16.3% of 26,481 IE patients were discharged AMA.
  • IE AMA patients were younger and had higher injection drug use (IDU) rates but fewer comorbidities.
  • IE AMA patients demonstrated a 3.1-fold increased hazard for 30-day readmissions (HR: 3.1; p < 0.01).

Conclusions:

  • Infective endocarditis patients discharged AMA face substantially higher 30-day readmission risks.
  • Higher resource utilization is observed for IE AMA readmissions.
  • Further research into mental health interventions for IE AMA patients with high IDU prevalence is warranted to reduce readmission burdens.
Abstract

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
13
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
23
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
23
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
14
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
23
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
18